Angel Pobo

Angel Pobo

Auto-generated profile, based on publicly available information

Angel Pobo

Univ Rovira & Virgili, Hosp Univ Tarragona Joan XXIII, Ctr Invest Biomed Red CIBER Enfermedades Resp, Serv Med Intens,Inst Invest Pere Virgil IISPV, Tarragona, Spain

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2009 in Chest
Verified
Journal Article
Closed access
APAngel Pobo
Angel Pobo
TLThiago Lisboa
Thiago Lisboa
ALEJANDRO HUGO RODRIGUEZ OVIEDOALEJANDRO HUGO RODRIGUEZ OVIEDO
ALEJANDRO HUGO RODRIGUEZ OVIEDO
RSRamiro Sole
Ramiro Sole
MMMónica Magret
Mónica Magret
JRJordi Rello
Jordi Rello

9 June 2007 in Intensive Care Medicine
Verified
Journal Article
Closed access
PDF file
JVJ. Vallés
J. Vallés
APA. Pobo
A. Pobo
OGO. García-Esquirol
O. García-Esquirol
DMD. Mariscal
D. Mariscal
JRJordi Real
Jordi Real
RFR. Fernández
R. Fernández

1 October 2006 in Anesthesiology
Verified
Journal Article
Closed access
JRJordi Rello
Jordi Rello
CACamilla Allegri
Camilla Allegri
ALEJANDRO HUGO RODRIGUEZ OVIEDOALEJANDRO HUGO RODRIGUEZ OVIEDO
ALEJANDRO HUGO RODRIGUEZ OVIEDO
LVLoreto Vidaur
Loreto Vidaur
GSGonzalo Sirgo
Gonzalo Sirgo
EDEmili Diaz
Emili Diaz
Background: To facilitate the decision-making process for therapy and prevention of ventilator-associated pneumonia (VAP) in patients undergoing recent antibiotic exposure, this study investigated whether the development of VAP episodes caused by Pseudomonas aeruginosa or other pathogens are related to different risk factors, thereby distinguishing two risk population for this serious complication. Methods: A 5-year retrospective case-control observational study was conducted. Cases of VAP caused by P. aeruginosa were compared with those caused by other pathogens. Univariate and multivariate analysis was performed using SPSS 11.0 software (SPSS Inc., Chicago, IL). Results: Two groups were identified: P. aeruginosa (group P) was isolated in 58 (63.7%) episodes, and 33 episodes served as controls (group C), after a median of 12 days (interquartile range, 4-28 days) and 9 days (interquartile range, 3-12.5 days) of mechanical ventilation, respectively. P. aeruginosa was identified in 34.7% of episodes with early-onset pneumonia and in 73.5% with late-onset pneumonia. In a logistic regression analysis, P. aeruginosa was independently associated with duration of stay of 5 days or longer (relative risk = 3.59; 95% confidence interval, 1.04-12.35) and absence of coma (relative risk = 8.36; 95% confidence interval, 2.68-26.09). Risk for pathogens different from P. aeruginosa (group C) in early-onset pneumonia associated with coma was estimated to be 87.5%. Conclusions: Risk factors in episodes under recent antibiotic treatment caused by P. aeruginosa or other microorganism are not the same, a fact that could have implications for preventive and therapeutic approaches for this infection.


12 June 2007 in Intensive Care Medicine
Verified
Journal Article
Closed access
PDF file
KAKemal Agbaht
Kemal Agbaht
TLThiago Lisboa
Thiago Lisboa
APAngel Pobo
Angel Pobo
ALEJANDRO HUGO RODRIGUEZ OVIEDOALEJANDRO HUGO RODRIGUEZ OVIEDO
ALEJANDRO HUGO RODRIGUEZ OVIEDO
ASAlberto Sandiumenge
Alberto Sandiumenge
JRJordi Rello
Jordi Rello

9 October 2010 in Medicina Clinica
Verified
Journal Article
Closed access
CCCarlos Carvajal
Carlos Carvajal
ÁPÁngel Pobo
Ángel Pobo
EDEmili Díaz
Emili Díaz
TLThiago Lisboa
Thiago Lisboa
MLMireia Llaurado-Serra
Mireia Llaurado-Serra
JRJordi Rello
Jordi Rello